Skip to main content
. 2016 May 19;11(5):e0155560. doi: 10.1371/journal.pone.0155560

Table 3. Antiretroviral regimens used by the participants.

Antiretroviral therapy regimens Participants who ever used the regimen
Zidovudine + Lamivudine + Nevirapine 82 (82%)
Tenofovir + Lamivudine + Nevirapine 65 (65%)
Stavudine + Lamivudine + Nevirapine 53 (53%)
Zidovudine + Lamivudine + Efavirenz 15 (15%)
Tenofovir + Lamivudine + Efavirenz 9 (9%)
Tenofovir + Emcitrabine + Nevirapine 2 (2%)
Tenofovir + Emcitrabine + Efavirenz 1 (1%)